Model Checkpoint Epoch: 3.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Neonatal morbidity is increased when there is an unacceptable degree of undernutrition, which may be determined by either low BF% or low birth weight. This study shows that BF% is a stronger predictor of neonatal morbidity than birth weight percentile. However, both measures should be considered together because they may complement each other. Low BF% is likely to be a more sensitive measure of undernutrition, whereas birth weight percentile provides information about the overall nutrient status of the neonate. Therefore, it is recommended to use both measures to determine the risk for neonatal morbidity. To ensure adequate nutritional support, it would be desirable to target neonates who have low BF% and/or those who are small for gestational age, as these measures will increase the likelihood of identifying those at highest risk of adverse outcome.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.8
Reasoning:
The assistant's answer is largely correct: it correctly states that BF% was a stronger predictor of neonatal morbidity than birth weight percentile and reasonably recommends using both measures together. It omits specific study findings (effect sizes) and does not explicitly note that BF% can identify appropriately grown yet undernourished neonates and exclude small neonates who are not at risk, which were key points in the ground truth. The recommendation to consider both measures is reasonable but slightly more interpretive than the study wording.

conciseness: 0.6
Reasoning:
The response answers the question directly (states BF% is a stronger predictor than birth weight percentiles and advises using both measures) but is somewhat repetitive and includes extra qualifying sentences that could be omitted. It could be more concise by stating the conclusion and recommendation in one or two short sentences and, if needed, citing the study's numeric effect sizes.

relevance: 0.9
Reasoning:
The assistant's reply directly answers the question by stating BF% is a stronger predictor of neonatal morbidity and recommends also considering birth weight percentiles together. This aligns with the study's finding that BF% is more closely associated with identifying neonates at risk and can detect infants who are appropriately grown yet undernourished; the response paraphrases the study rather than quoting it verbatim but remains relevant to the provided context.

coherence: 0.8
Reasoning:
The response is clear and well organized: it states the main conclusion (BF% is a stronger predictor), summarizes implications (use both measures), and gives a practical recommendation. It is coherent in argument flow and terminology, though it omits specific study details (effect sizes, definitions) and makes a few general assertions without citing the reported statistics. Overall the answer is logically structured and easy to follow.

helpfulness: 0.8
Reasoning:
The assistant's reply correctly states the main conclusion from the study — that neonatal BF% shows a stronger association with neonatal morbidity than birth weight percentile — and is concise and actionable in recommending that both measures be used together to improve identification of at-risk infants. It aligns with the ground truth that BF% can identify undernourished infants who are appropriately grown by weight. Minor weaknesses: it makes a somewhat stronger claim about BF% being "more sensitive" without reporting the study's specific measures (ORs, prevalence, or how "low BF%" was defined) and does not note study limitations or population context that could affect generalizability.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The majority of patients affected by ischemic Charcot neuroarthropathy presenting with foot lesions can be treated successfully with endovascular revascularization, surgical and orthopedic treatment. Limb salvage can be achieved in most cases. However, in some cases, the infection cannot be controlled and an above knee amputation may be necessary. Moreover, the time required to heal the lesion is longer than that reported for other forms of Charcot neuropathy. This study confirms the importance of early diagnosis and prompt treatment of these patients. Further studies are needed to define the best treatment approach for this condition.
The current report highlights the efficacy of endovascular revascularization, surgery and orthopaedic treatment in a selected group of patients affected by ischaemic Charcot neuroarthropathy. The results confirm that ischemic Charcot neuroarthropathy should be considered as a distinct entity from the classic form of Charcot neuropathy and it should be treated accordingly. Future prospective studies are needed to establish the optimal treatment protocol for this condition.
In addition, we observed a significant difference in the outcome of treatment in patients affected by ischaemic Charcot neuroarthropathy compared with those affected by classical Charcot neuropathy. The indications for surgery and the timing of the procedure should be carefully defined. Furthermore, further studies on the use of biologics and the use of adjuvant therapies are warranted.
Finally, it is important to emphasize the importance of multidisciplinary management of these patients. We recommend that all patients affected by ischaemic Charcot neuroarthropathy be treated by a team including vascular surgeons, podiatrists, orthopaedic surgeons, rheumatologists, and infectious diseases specialists.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.6
Reasoning:
Short explanation:
The assistant's answer correctly emphasizes that ischemic Charcot neuroarthropathy often requires revascularization together with surgical and orthopedic care and that limb salvage is achievable (the cited 90% limb salvage aligns with the study). It appropriately stresses early diagnosis, multidisciplinary care, and need for further research. However, it also contains inaccuracies and overstatements: the response claims an above‑knee amputation may be necessary (the study reported a below‑knee amputation in the single failure), asserts a “significant difference in outcome” versus classical Charcot without comparative data, and broadly labels the condition as a distinct entity requiring different treatment without clearly qualifying that this conclusion is based on a small, selected series. Inclusion of rheumatologists in the recommended core team is atypical for this condition. Overall the reply is partly accurate but includes unsupported or incorrect statements and some imprecise wording.

conciseness: 0.3
Reasoning:
The assistant's reply answers the question but is verbose and repetitive, restating the same points in multiple paragraphs and adding unsupported or slightly incorrect specifics (it mentions above‑knee amputation though the study reported a below‑knee amputation). It could be much more concise by stating the key conclusions once: ischemic Charcot is a distinct, ischemia‑driven variant that usually requires revascularization plus surgical/orthopedic care for limb salvage and multidisciplinary management; outcomes and healing times may be worse than classic Charcot and further studies are needed.

relevance: 0.5
Reasoning:
Explanation: The assistant's reply is relevant to the question and does answer it (it states that ischemic Charcot neuroarthropathy should be considered a distinct entity requiring specific management and that endovascular revascularization plus surgical/orthopaedic treatment can achieve limb salvage). The response also echoes facts from the context (limb salvage is achievable; infection may lead to amputation; healing is prolonged). However, it includes factual errors and unsupported extrapolations: the original report described a below‑the‑knee amputation in the single failure, not an above‑knee amputation; the study provided no direct comparison group to support the claim of a "significant difference" versus classic Charcot neuropathy; and several recommendations (specific specialist mix, comments about biologics) extend beyond the presented data. Overall the answer is relevant but partly inaccurate and overinterprets the limited retrospective data.

coherence: 0.7
Reasoning:
The response is generally coherent and organized: it directly addresses whether ischemic Charcot foot should be considered a different entity with distinct treatment, summarizes key outcomes (limb salvage, longer healing, possible amputation), and emphasizes early diagnosis and multidisciplinary care. However, it is somewhat repetitive, makes at least one inconsistent factual statement (mentions above‑knee amputation while the data reported a below‑knee amputation), and asserts a "significant difference" versus classical Charcot without presenting supporting comparative data. Tightening phrasing, avoiding unsupported claims, and aligning specific details with the reported data would improve clarity.

helpfulness: 0.5
Reasoning:
The response captures the main practical points (endovascular revascularization plus surgical/orthopaedic care can achieve high limb-salvage rates, prolonged healing times, need for early/multidisciplinary management, and the need for further study). However, it also contains factual and evidentiary weaknesses: it incorrectly states an "above-knee" amputation occurred when the study reported a below-knee amputation; it asserts a "significant difference" in outcomes versus classic Charcot without a comparator or supporting data; and it repeats points and adds some speculative recommendations (e.g., specific adjuvant therapies) without evidence from the presented study. Overall the answer is reasonably helpful and clinically oriented but marred by factual inaccuracy and unsupported claims.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Type of surgery did not affect the survival outcomes in this cohort. Although RH could be an effective treatment modality, it might be unnecessary for patients with endometrial cancer without suspected cervical involvement. Further studies are required to determine whether SH or mRH would also provide similar survival outcomes. In addition, RH may have been associated with more complications than SH or mRH. Gynecologists should carefully consider individual patient characteristics and preferences when selecting a surgical strategy. Surgeons should perform careful intraoperative examination of uterine cervix to avoid unnecessary radical hysterectomy. This study provides insights into the role of radical hysterectomy in patients with endometrial cancer with suspected cervical involvement. These data will help guide clinicians' decision-making regarding surgical management.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.6
Reasoning:
The response correctly states the main findings that type of hysterectomy did not improve survival and that radical hysterectomy (RH) was associated with more complications. However, it contains a factual error (it says RH might be unnecessary "for patients with endometrial cancer without suspected cervical involvement" when the study population had suspected gross cervical involvement) and adds speculative language ("RH could be an effective treatment modality") not supported by the reported results. It also omits specific mention that hysterectomy type was not an independent prognostic factor for local recurrence-free survival, PFS, and OS, and that the authors call for prospective studies. Overall the answer is mostly accurate but has a notable factual slip and some unsupported wording.

conciseness: 0.5
Reasoning:
The reply correctly notes no survival benefit from radical hysterectomy (RH) in this cohort and that RH was associated with more complications, but it contains a factual inaccuracy and is somewhat redundant. Specifically, the answer mistakenly refers to patients "without suspected cervical involvement" even though the study population had suspected gross cervical involvement. It also adds repetitive clinical advice beyond the study findings, reducing conciseness.

relevance: 0.6
Reasoning:
The assistant's reply is partially relevant: it correctly states the main finding that hysterectomy type did not affect survival outcomes and correctly notes higher complication rates with radical hysterectomy, which align with the study context. However it includes at least one incorrect or misleading statement (saying RH "might be unnecessary for patients with endometrial cancer without suspected cervical involvement" when the study addressed patients with suspected gross cervical involvement) and adds recommendations and speculation not directly supported by the presented data. Overall the response answers the question but contains inaccuracies and unwarranted extrapolation.

coherence: 0.6
Reasoning:
The assistant's reply is generally coherent and organized: it states the main finding (no survival benefit from radical hysterectomy), notes increased complications with RH, and suggests individualized decision-making and the need for further studies. However it contains a notable contextual error — it refers to RH being "unnecessary for patients with endometrial cancer without suspected cervical involvement," which is irrelevant to the presented study population (the study specifically examined patients with suspected gross cervical involvement). That incorrect clause reduces the answer's accuracy and coherence relative to the question. Overall the response summarizes results and implications clearly but includes one misleading sentence and some vague recommendations.

helpfulness: 0.6
Reasoning:
The assistant's response correctly conveys the study's main finding that type of hysterectomy did not affect survival and notes increased complications with radical hysterectomy, which are the most important points for clinicians. However, it contains a factual inaccuracy (saying RH might be unnecessary "for patients with endometrial cancer without suspected cervical involvement" — the study concerned patients with suspected gross cervical involvement) and some vague or contradictory phrasing ("RH could be an effective treatment modality" despite no observed survival benefit). The answer also omits some useful specific details (e.g., longer operative time, higher transfusion rates, severe urinary dysfunction, and that age/grade/peritoneal cytology/lymph node status were the identified prognostic factors). Overall it is generally helpful but imprecise and slightly misleading.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are associated with poor outcomes. To prevent these readmissions, careful patient selection and optimization of perioperative care are crucial. This may include minimizing the length of stay, improving nutritional support, and providing adequate pain management. In addition, close follow-up care during the early postoperative period is essential. Further studies are warranted to determine whether specific interventions such as prophylactic antibiotics or other strategies could reduce the risk of readmissions after PD. Prospective trials evaluating the impact of specific interventions should be performed. To determine the effectiveness of these interventions, it is important to monitor readmission rates and other outcomes such as survival, complication rates, and quality of life. Ultimately, the goal is to improve the quality of care and patient outcomes.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.3
Reasoning:
The assistant’s reply is vague and does not accurately reflect the study’s main findings. It omits the two independent predictors identified (pancreatic fistula and complex/multivisceral resection), fails to note that half of readmissions occur within 7 days (so prevention efforts should target early post-discharge care), and even suggests “minimizing length of stay” without acknowledging the study’s finding that a length of stay >7 days was associated with readmission (a nuanced interpretation is needed). The recommendations are generic (improve nutrition, pain control, early follow-up, further trials) and not tied to the study’s specific actionable predictors or timing. Overall the answer is imprecise and incomplete relative to the ground truth.

conciseness: 0.3
Reasoning:
The response is brief but overly generic and fails to address the key study findings that would most directly guide prevention: it does not mention pancreatic fistula or complexity/multivisceral resection as independent predictors, nor emphasize preventing early (≤7 day) readmissions which made up half of cases. While concise, it is not sufficiently targeted to the evidence presented and therefore of limited usefulness.

relevance: 0.3
Reasoning:
The assistant's reply gives general prevention strategies for readmission after PD but fails to reference the study's specific, relevant findings (eg, pancreatic fistula and complex/multivisceral resection being independently associated with readmissions, and that ~50% of readmissions occur within 7 days). It also suggests measures (minimizing length of stay, prophylactic antibiotics) without tying them to the reported data and in one case (minimizing LOS) risks contradicting the study's finding that initial hospital stay >7 days was associated with readmission. Because it does not refer to real quotes or key results from the provided context, its relevance to the question as framed by the study is low.

coherence: 0.5
Reasoning:
The response is generally coherent and organized: it opens with a clear statement of the problem, lists several broad prevention strategies (patient selection, perioperative optimization, nutrition, pain control, early follow-up), and ends with a reasonable call for prospective study and outcome monitoring. However, it is quite generic and not well linked to the study findings presented in the prompt — it fails to highlight the study’s specific independent predictors (pancreatic fistula, multivisceral resection, prolonged initial stay, ICU admission) or the fact that roughly half of readmissions occur within 7 days (thus prioritizing prevention of early readmissions). It also ambiguously recommends “minimizing length of stay,” which conflicts with the study’s finding that longer initial stay is associated with readmission and would benefit from clearer, evidence-aligned recommendations (e.g., targeted fistula-prevention strategies, early postdischarge contact, drain management protocols). Overall the answer is organized but lacks specificity and direct engagement with the data.

helpfulness: 0.4
Reasoning:
The response is generic and only partially helpful. It recommends broad perioperative optimization and early follow-up, which are reasonable, but it fails to cite or incorporate the specific study findings (pancreatic fistula and complex/multivisceral resections as independent predictors, ICU admission and length of stay >7 days) and does not emphasize that half of readmissions occur within 7 days — a key point that supports targeting very early postdischarge interventions. The suggestion to "minimize length of stay" is potentially misleading given the study found prolonged initial LOS (>7 days) was associated with readmission (the implication is not simply to shorten stay). The answer also lacks concrete, actionable strategies tied to the identified risk factors (e.g., measures to prevent or monitor pancreatic fistula, planned early clinic or phone follow-up within 7 days, drainage management, or targeted care pathways for multivisceral resections). Overall useful at a high level but not evidence-aligned or sufficiently specific.

================================================================================
Average correctness Score: 0.525
Average conciseness Score: 0.485
Average relevance Score: 0.54
Average coherence Score: 0.59
Average helpfulness Score: 0.52
